AzTrials
AzTrials

Infantile Spinal Muscular AtrophyBAINSMANCT06152302

Test of Aquatic Mobility of SMA Infants

A study testing Mobility study in dry conditions and Mobility study in water conditions in people with Infantile Spinal Muscular Atrophy, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Spinal muscular atrophy (SMA) is a genetic neurodegenerative disease impacting spinal cord motor neurons, leading to motor and respiratory issues and, ultimately, death. With emerging therapies, a need arises to enhance motor function assessment in severely hypotonic infants (SMA type 1) as traditional scales on… Read more about this study

Who is it for?
Ages Up to 12 months
Conditions the study is for
Infantile Spinal Muscular Atrophy
What is being tested?
Mobility study in dry conditions and Mobility study in water conditions
Could I receive a placebo?
No, everyone receives an active treatment
How many people
15 participants
Where
1 siteFrance
Study dates
26 Jun 2025to Jun 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 12 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Infants with muscle weakness (commonly referred to as floppy babies):
  • Confirmed diagnosis of SMA through gene mutation or deletion (SMN1 gene).
  • Receiving standard care.
  • Age less than 12 years and a height of less than 90 cm at the time of inclusion.
  • Patients enrolled in a social security scheme.
  • Informed consent signed by both parents of the child and the investigator.

Who cannot join

  • Patients presenting with lesions in the spinal cord or conditions affecting the cardiorespiratory system.
  • Patients covered under the French Aid in Health for Foreign People program (AME).

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Susana Quijano-Roy, MD, PhD contact

+ 33 1 47 10 78 90

susana.quijano-roy@aphp.fr

Nour Maalouf, Psychomotor Therapist DE contact

nour.maalouf@outlook.com

France1 site, 1 recruiting
  • Infantile neuromuscular unity - Department of paediatric neurological care and intentive care unity, Raymond Poincaré Hospital - APHP

    Garches, 92380

    Nour Maalouf, Master of psychology, maaloufnour@yahoo.fr

    Marta Gomez Garcia de la Banda, MD

    Recruiting

Other trials in France

About this study

Official title: Analysis of Mobility in the Bath for Infants Affected With Spinal Muscular Atrophy

Spinal muscular atrophy (SMA) is a genetic neurodegenerative disease impacting spinal cord motor neurons, leading to motor and respiratory issues and, ultimately, death. With emerging therapies, a need arises to enhance motor function assessment in severely hypotonic infants (SMA type 1) as traditional scales on examination tables lack completeness due to gravity's influence.

The study team has developed a "bath test" to observe infants' motor skills in water, eliminating gravity's effects. This test aims to detect subtle movements using inertial sensors, potentially revealing more active motor neurons in aquatic conditions. It aids in identifying infants with motor improvement potential, even if they show limited mobility outside water, and tracks disease progression and therapy responses.

Read more

Presently, pediatric neurologists in France use parent-provided bathing videos for evaluations, but these lack standardization and precision. The study aims to establish a standardized evaluation protocol with quantifiable data.

The study's key objective is to evaluate severely hypotonic SMA infants using inertial sensors, including accelerometers, gyrometers, and magnetometers. The study will conduct "dry" and "water" assessments using a specially designed bathtub. This method's goal is to quantify water-based movements accurately.

Simultaneously, the study seeks to establish semi-quantitative evaluation criteria to create a clinical assessment scale for infant motor function in bathtubs. This scale will aid doctors in therapeutic decisions. The study will not influence the treatment or therapeutic decisions made for the children being tested.

Collected data from "dry" and "water" conditions will be statistically analyzed and compared to reference motor assessment scales (e.g., CHOP INTEND and HINE) and electromyography (CMAP-EMG) results, commonly used in diagnosis and monitoring. Blurred video recordings will assist in protocol monitoring and sensor data analysis.

Read the detailed description

This is a multicenter research project coordinated by the Child Neuromuscular Unit at Raymond Poincaré Hospital. Additionally, two other pediatric neurology departments, part of the national neuromuscular network FILNEMUS (https://www.filnemus.fr/), will participate in the study: Necker Children's Hospital and Armand Trousseau Hospital.

The study's population will include all infants diagnosed with spinal muscular atrophy (SMA), specifically SMA type 1, who have onset before 6 months of age and have been evaluated by the French Therapeutic Commission. Participation in the study will be contingent on parental or guardian consent during follow-up visits.

Spinal muscular atrophy is a genetic neurodegenerative condition that affects spinal motor neurons, causing motor and respiratory paralysis and ultimately leading to death. As groundbreaking therapies emerge, there's an increasing need to refine the methods used to assess motor function, especially in infants with severe hypotonia due to SMA type 1. Traditional reference scales used on examination tables are limited in their accuracy because of gravitational effects. Consequently, there's growing interest in evaluating these children's motor skills in water to detect movements unburdened by gravity. Pediatric neurologists in France (SFNP) have already acknowledged the potential value of parental video recordings during infant baths. However, the lack of standardization in recording conditions, coupled with the subjective nature of video interpretations, underscores the necessity for a more standardized and quantifiable approach. Herein lies the application of our proposed evaluation utilizing inertial sensors.

Utilizing inertial sensors to detect subtle movements can highlight still-active yet minimally functional motor neurons. Such detection can be pivotal in identifying children who, despite severe motor skill limitations in traditional settings, still possess developmental potential. Our study seeks to leverage these sensors-equipped with accelerometers, gyroscopes, and magnetometers-to carry out evaluations both in ''dry'' conditions and ''water'' conditions, using a specially designed, secure bathtub.

The study aims to validate the relevance of quantifying movements in aquatic settings using inertial sensors, in order to assess motor function in very hypotonic children. Additionally, this study will contribute to the development of a semi-quantitative clinical evaluation grid for assessing infant motor function in water, assisting physicians in making more informed therapeutic decisions for these children. Data obtained from measurements with inertial sensors in both environments ("dry" and "water") will be correlated with scores from validated motor scales (CHOP INTEND; HINE-2) and the clinical characteristics of the patients (e.g., age, disease duration, SMA type, SMN2 copies, severity, CMAPs [EMG]). Anamnestic, clinical and inertial data will be anonymized.

The equipment required for the protocol comprises an examination table, a bath, a support for the head and back (https://www.neut.fr/fr/), 8 CE-validated Xsens DOT© inertial sensors, a dedicated research smartphone with the Xsens DOT© application for data export, a camera mounted on a pole connected to an acquisition tablet. The study will utilize a fixed PC computer with secure access, located in a dedicated research room within the Pediatric Neurology and Intensive Care Unit at Raymond Poincaré Hospital.

Video recording throughout the evaluation will be carried out from an overhead perspective, capturing all four limbs in the frame and ensuring that the child occupies approximately 50% of the camera's field of vision. To comply with privacy regulations (MR-001), the videos will obscure any identifying features, such as faces or other body parts of the patients. These videos will serve as a reference for controlling and validating the data collected by the inertial sensors.

The study's outputs will include inertial data from 8 inertial sensors placed on the arms (2), forearms (2), thighs (2), and legs (2). Our motor evaluation process is split into two distinct phases, totaling 6 minutes: a "dry" phase affected by gravity, and a "water" phase where gravity's effects are mitigated. The surrounding time is allocated for essential tasks such as positioning the child, fitting the sensors, and ensuring the infant's comfort throughout the process. Notably, our study doesn't seek to alter the standard care or therapeutic decisions for the participants.

The measurements will follow a specific process:

  • "Dry" phase: This involves evaluating limb movements under the constraints of gravity. The child is placed in a supine position on the examination table set horizontally (0°). To minimize signal artifacts, physical contact with the child should be avoided. If the child's behavior is unfavorable (e.g., crying), the measurement is paused and resumed once the child's condition stabilizes. Spontaneous or induced movements are collected for 2 minutes, with the entire duration filmed for monitoring the inertial sensor data.
  • Intermediate phase: The diaper is removed, and the child is positioned in a support inclined at 20°, then transferred to the bathtub. This transition should be made in a reassuring manner for the child, respecting their pace of adaptation.
  • "Water" phase: This phase involves evaluating limb movements without gravity constraints. Spontaneous or induced movements are collected for 4 minutes, with the entire duration filmed for monitoring the inertial sensor data. Measurements may also be paused and resumed based on the child's behavior.

The processes of sensor installation and sensor removal are accompanied by sensorimotor stimulation.

Being tested
Mobility study in dry conditions, Mobility study in water conditions
Keywords
SMA, infantile, bath test, water mobility test, inertial sensors, floppy infant, Garches
Medical subject headings
Spinal Muscular Atrophies of Childhood, Muscle Hypotonia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mobility study in dry conditionsOther

    Record the movements of the baby's extremities using inertial sensors while the baby moves outside of the water.

  • Mobility study in water conditionsOther

    Also called Garches Bath Test (GBT)

    Record the movements of the baby's extremities using inertial sensors while the baby moves inside the water.

Study groups in NCT06152302
Study groupRoleWhat they receive
Mobility AssessmentExperimentalThis study involves a single arm, without a comparator group. The comparison will be made between the data for movements in conditions outside the water and inside the water.
Receives: Other: Mobility study in dry conditions; Other: Mobility study in water conditions

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Delta of 95th percentile of free acceleration norm (in m/s²)

    Difference of free acceleration norm (in m/s²) for each measurement point respectively (elbows; wrists; knees; ankles), between "dry" and "water" condition.

    Measured: through study completion, an average of 15 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Nov 2023
  2. Study start26 Jun 2025
  3. Primary completionJun 2026 (estimated)
  4. Study completionJun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Factorial
Model description
There is one arm in this study, without comparator group. The comparison will be between data of movements in the outside water condition and data of inside water condition.
Masking
None (open label)
Enrolment
15 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06152302
Sponsor's protocol ID
APHP231293
Other IDs
2022-A01419-34
Acronym
BAINSMA
Status last verified
Sep 2025
First submitted
30 Oct 2023
Last updated
21 Nov 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Mobility study in dry conditions and Mobility study in water conditions in people with Infantile Spinal Muscular Atrophy, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 21 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Susana Quijano-Roy, MD, PhD (+ 33 1 47 10 78 90, susana.quijano-roy@aphp.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Delta of 95th percentile of free acceleration norm (in m/s²) (time frame: through study completion, an average of 15 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Nov 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in